Low employee moral at Merck. - werkgeversreview Anonieme werknemer bij Merck

3,0
16 jan 2009
Anonieme werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent values and principles that really point the direction leaders must follow. Excellent compensation and genuine interest in continuous improvement in all aspects of the business. Need for change is clear in leaders' minds. Flexibility and customer focus being valued more as it is enforced within the new culture. More frequent communication and webcasts by Senior Corporate Management through e-mails and web casts as compared to previous CEO. More open culture approaching a risk-taking attitude. Work/life balance is very much emphasized and encouraged among all employees.

Minpunten

Hysterical downsizing. Lack of judgement and appreciation for people that really get the job done. Favoritism. Aristocratic and dictatorial style by local senior management not allowing true challenging of the status quo. Works like a Company surrounded by mirrors with appreciation of outside world. Arrogant style. Lack of authenticity. Full pipeline but no quantifiable results.

Ontdek andere reviews over Merck

5,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Excellent company to work with.

Minpunten

No cons encountered so far

4,0
30 jun 2026
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht

Pluspunten

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Minpunten

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bekijk reviews op: Nuttig|Beoordeling|Datum|Alle